INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,650 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CF
Claffee Lily FuDirector
JXNJackson Financial Inc.
Grant or award
A—
399 sh
Jun 25, 2026Jun 29, 2026
Page 604 of 1717
← PrevNext →
traded Jun 25, 2026
+4d
SEC Form 4

Evidence

9
SP
Sudhanshu PriyadarshiCFO & President, International
PLNTPlanet Fitness, Inc.
Grant or award
A—
92.8K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
NG
Noles Russell GDirector
JXNJackson Financial Inc.
Grant or award
A—
189 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
14 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
152 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
14 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RV
Renda Rudolph V.Director, CO-COO AND EVP, 10% Owner
SLNDSouthland Holdings, Inc.
Option exercise
M—
15.7K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LD
Lawton DrewDirector
JXNJackson Financial Inc.
Grant or award
A—
252 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
26 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
32 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
40.0K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
FA
Forbes AlexandriaDirector, PRESIDENT & CEO
MGTXMeiraGTx Holdings plc
Grant or award
A—
980.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
AK
Agger Mette KirstineDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
ZK
Zeldin Robert KCHIEF MEDICAL OFFICER
MGTXMeiraGTx Holdings plc
Grant or award
A—
100.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
64 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CB
Cooperstone BrendaDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
197 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
SE
Stecher Esta EDirector
JXNJackson Financial Inc.
Grant or award
A—
430 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CC
Chelko CarrieEVP and General Counsel
JXNJackson Financial Inc.
Grant or award
A—
41 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CC
Chelko CarrieEVP and General Counsel
JXNJackson Financial Inc.
Grant or award
A—
49 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
VT
Van Hauwermeiren TimothyDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
WJ
Wollin Robert JGENERAL COUNSEL AND SECRETARY
MGTXMeiraGTx Holdings plc
Grant or award
A—
100.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CS
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
95.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CE
Crowley ElizabethSR. VP & CPDO
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
100.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CS
Campbell ShannonDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
40.0K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

8
CC
Cushman Elizabeth C.EVP, GC AND SECRETARY
ABTABBOTT LABORATORIES
Tax withholding
F$53K
560 sh
Jun 27, 2026Jun 29, 2026
traded Jun 27, 2026
+2dSEC Form 4

Evidence

8
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Tax withholding
F$151K
1,056 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

8
AH
Anderson David HugoDirector
NWNNorthwest Natural Holding Co
Open-market sale · 10b5-1 plan
SELL$76K
1,500 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$26K
79 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$36K
110 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$49K
150 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

6
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,200 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

5
SS
Shah Aarti S.Director
NVDANVIDIA CORP
Grant or award
A—
1,211 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
WD
Wilkins Joseph D Jr.Director
QDELQuidelOrtho Corp
Grant or award
A—
15.5K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
GK
Goodrich KatherineDirector
TARSTarsus Pharmaceuticals, Inc.
Grant or award
A—
2,417 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
LA
Leggett Michael AdamSr VP & Chief Supply Chain Off
LZBLA-Z-BOY INC
Tax withholding
F$15K
365 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence

5
NS
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY
MGTXMeiraGTx Holdings plc
Grant or award
A—
70.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
JA
Janmohamed ArifDirector
NAVNNavan, Inc.
Grant or award
A—
9,959 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
ML
McCurry Jennifer LynnChief Accounting Officer
LZBLA-Z-BOY INC
Tax withholding
F$10K
253 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence